In the context of cancer, epigenetic dysregulation can lead to the activation of oncogenes or the silencing of tumor suppressor genes, contributing to tumorigenesis. Unlike genetic mutations, which are permanent, epigenetic changes are potentially reversible, offering unique opportunities for therapeutic interventions.
